Product
AZD 1222
2 clinical trials
2 indications
Indication
COVID-19 VaccinationIndication
COVID-19Clinical trial
Blood Donations From Healthy Probands for the Study of the Adaptive Immune Response to COVID-19 Vaccination (AICOVI)Status: Active (not recruiting), Estimated PCD: 2021-12-13
Clinical trial
Open-Label, Single-Arm, Phase 3b Study of the Incidence of Severe COVID-19 and Adverse Events Following AZD1222 COVID-19 Vaccination in Botswana Against SARS-CoV-2, AZD1222 - ESR-21-21311Status: Completed, Estimated PCD: 2022-12-30